Literature DB >> 11867116

W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.

Susan J M Hahné, Steve J Gray, Natasha S Crowcroft, Tom Nichols, Edward B Kaczmarski, Mary E Ramsay.   

Abstract

An outbreak of W135 meningococcal disease was seen in 2000 and 2001 among pilgrims returning from Saudi Arabia and their contacts. The Public Health Laboratory Service set up enhanced surveillance to monitor spread and virulence of the outbreak strain, and to collect data on case characteristics. The number of cases reported from England and Wales in 2001 was similar to the number reported during 2000, despite a change in the recommendation for pilgrims to receive quadrivalent vaccine (against serogroup A, C, W135, and Y) instead of the A/C vaccine recommended in 2000. Both the recommendation and vaccine were not available until January, 2001, and coverage among pilgrims to the Hajj 2001 was low. The case--fatality ratio was high, and sustained transmission of the virulent outbreak strain was seen. Current control policies, both in primary and secondary prevention, might need better implementation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867116     DOI: 10.1016/s0140-6736(02)07716-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience.

Authors:  H Findlow; R Borrow
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

2.  Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters.

Authors:  Andrew Birtles; Katie Hardy; Stephen J Gray; Suzanne Handford; Edward B Kaczmarski; Valerie Edwards-Jones; Andrew J Fox
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 3.  Neisseria meningitidis: biology, microbiology, and epidemiology.

Authors:  Nadine G Rouphael; David S Stephens
Journal:  Methods Mol Biol       Date:  2012

Review 4.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.

Authors:  Ana Paula S Lemos; Lee H Harrison; Melina Lenser; Claudio T Sacchi
Journal:  J Infect       Date:  2010-01-06       Impact factor: 6.072

6.  Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.

Authors:  Muhamed-Kheir Taha; Dario Giorgini; Magaly Ducos-Galand; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  Influenza and respiratory syncytial virus infections in British Hajj pilgrims.

Authors:  H Rashid; S Shafi; R Booy; H El Bashir; K Ali; Mc Zambon; Za Memish; J Ellis; Pg Coen; E Haworth
Journal:  Emerg Health Threats J       Date:  2008-02-29

8.  Meningococcal disease in South Africa, 1999-2002.

Authors:  Garry B Coulson; Anne von Gottberg; Mignon du Plessis; Anthony M Smith; Linda de Gouveia; Keith P Klugman
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

9.  Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Sindhu Ravindran; Arul Earnest; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Suok Kai Chew; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.